Join us as Dr Laura Biganzoli, Dr Sonia Pernas, Dr Peter Fasching discuss the latest results for emerging HER2-targeted therapies in patients with advanced breast cancer.
This activity is funded by an independent medical education grant from Seagen. This activity is provided by touchIME.
🔸Don't forget to sign up to email alerts on our touchONCOLOGY website to keep up to date with all news, topics and new activities available here: [ Ссылка ]
🔸You can also follow us on:
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
#Oncology #BreastCancer #ClinicalPractice #ESMO #ASCO #Cancer
#LauraBiganzoli #SoniaPernas #PeterFasching
